TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 11, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today [...] Read more »
Cellebrite’s Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 06, 2025 (GLOBE NEWSWIRE) — Read more »
Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD–19 x FcγRIIb inhibitor of B cell function–
–Topline results from Phase 2 Trial in [...] Read more »
Lantronix Lança LM4, Nova Plataforma Out-of-Band Management Alimentada por IA na Cisco Live
IRVINE, Califórnia, Feb. 05, 2025 (GLOBE NEWSWIRE) — A Read more »
Lantronix stellt auf der Cisco Live erstmals die neue LM4-Out-of-Band-Management-Plattform mit KI-Unterstützung vor
IRVINE, Kalifornien, Feb. 05, 2025 (GLOBE NEWSWIRE) — Read more »
Lantronix présentera sa nouvelle plateforme de gestion hors bande LM4 alimentée par l’IA au salon Cisco Live
IRVINE, Californie, 05 févr. 2025 (GLOBE NEWSWIRE) — Read more »
Lantronix to Debut New LM4 AI-Powered Out-of-Band Management Platform at Cisco Live
IRVINE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) — Read more »
Zoom to Release Financial Results for the Fourth Quarter and Full Fiscal Year 2025
SAN JOSE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the fourth quarter and full fiscal year 2025 on Monday, February 24, [...] Read more »
Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference
WALTHAM, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical–stage global biopharmaceutical company committed to being a [...] Read more »
Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
JERUSALEM, Jan. 27, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, [...] Read more »